META MATERIALS INC (MMAT) Fundamental Analysis & Valuation

NASDAQ:MMAT • US59134N3026

Current stock price

0.5258 USD
-0.11 (-17.84%)
At close:
0.5013 USD
-0.02 (-4.66%)
After Hours:

This MMAT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. MMAT Profitability Analysis

1.1 Basic Checks

  • In the past year MMAT has reported negative net income.
  • MMAT had a negative operating cash flow in the past year.
  • MMAT had negative earnings in each of the past 5 years.
  • MMAT had a negative operating cash flow in each of the past 5 years.
MMAT Yearly Net Income VS EBIT VS OCF VS FCFMMAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -100M -200M -300M

1.2 Ratios

  • MMAT has a Return On Assets of -834.91%. This is amonst the worse of the industry: MMAT underperforms 99.08% of its industry peers.
  • With a Return On Equity value of -2111.11%, MMAT is not doing good in the industry: 95.41% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -834.91%
ROE -2111.11%
ROIC N/A
ROA(3y)-253.79%
ROA(5y)-164.97%
ROE(3y)-621.14%
ROE(5y)-405.97%
ROIC(3y)N/A
ROIC(5y)N/A
MMAT Yearly ROA, ROE, ROICMMAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 -500 -1K -1.5K

1.3 Margins

  • Looking at the Gross Margin, with a value of 66.75%, MMAT belongs to the top of the industry, outperforming 88.99% of the companies in the same industry.
  • MMAT's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for MMAT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y183.27%
GM growth 5Y9.66%
MMAT Yearly Profit, Operating, Gross MarginsMMAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -2K -4K -6K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. MMAT Health Analysis

2.1 Basic Checks

  • MMAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, MMAT has more shares outstanding
  • The debt/assets ratio for MMAT is higher compared to a year ago.
MMAT Yearly Shares OutstandingMMAT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
MMAT Yearly Total Debt VS Total AssetsMMAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

  • MMAT has an Altman-Z score of -21.69. This is a bad value and indicates that MMAT is not financially healthy and even has some risk of bankruptcy.
  • MMAT has a Altman-Z score of -21.69. This is amonst the worse of the industry: MMAT underperforms 87.16% of its industry peers.
  • MMAT has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
  • MMAT has a Debt to Equity ratio (0.16) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z -21.69
ROIC/WACCN/A
WACC8.82%
MMAT Yearly LT Debt VS Equity VS FCFMMAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 0.58 indicates that MMAT may have some problems paying its short term obligations.
  • MMAT has a worse Current ratio (0.58) than 94.50% of its industry peers.
  • MMAT has a Quick Ratio of 0.58. This is a bad value and indicates that MMAT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.57, MMAT is doing worse than 91.74% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.58
Quick Ratio 0.57
MMAT Yearly Current Assets VS Current LiabilitesMMAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. MMAT Growth Analysis

3.1 Past

  • MMAT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.87%, which is quite impressive.
  • Looking at the last year, MMAT shows a quite strong growth in Revenue. The Revenue has grown by 13.75% in the last year.
  • MMAT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 44.10% yearly.
EPS 1Y (TTM)36.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.6%
Revenue 1Y (TTM)13.75%
Revenue growth 3Y245.59%
Revenue growth 5Y44.1%
Sales Q2Q%131.54%

3.2 Future

  • The Earnings Per Share is expected to grow by 26.10% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 175.50% on average over the next years. This is a very strong growth
EPS Next Y25.62%
EPS Next 2Y41.4%
EPS Next 3Y26.1%
EPS Next 5YN/A
Revenue Next Year312.22%
Revenue Next 2Y289.54%
Revenue Next 3Y175.51%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MMAT Yearly Revenue VS EstimatesMMAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
MMAT Yearly EPS VS EstimatesMMAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -5 -10 -15 -20 -25

More info and screens

Find the best growth stocksShow best growing peers

1

4. MMAT Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MMAT. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MMAT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MMAT Price Earnings VS Forward Price EarningsMMAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MMAT Per share dataMMAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as MMAT's earnings are expected to grow with 26.10% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.4%
EPS Next 3Y26.1%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MMAT Dividend Analysis

5.1 Amount

  • No dividends for MMAT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

MMAT Fundamentals: All Metrics, Ratios and Statistics

META MATERIALS INC

NASDAQ:MMAT (8/20/2024, 8:00:00 PM)

After market: 0.5013 -0.02 (-4.66%)

0.5258

-0.11 (-17.84%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Industry Strength100
Industry Growth0.75
Earnings (Last)03-28
Earnings (Next)N/A
Inst Owners0.86%
Inst Owner Change5000%
Ins Owners317.51%
Ins Owner Change0%
Market Cap3.33M
Revenue(TTM)9.83M
Net Income(TTM)-387.07M
Analysts82.86
Price Target122.4 (23178.81%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)61.52%
Min EPS beat(2)42.65%
Max EPS beat(2)80.39%
EPS beat(4)4
Avg EPS beat(4)41.54%
Min EPS beat(4)21.57%
Max EPS beat(4)80.39%
EPS beat(8)5
Avg EPS beat(8)12.03%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-32.06%
Min Revenue beat(2)-46.31%
Max Revenue beat(2)-17.8%
Revenue beat(4)0
Avg Revenue beat(4)-24.91%
Min Revenue beat(4)-46.31%
Max Revenue beat(4)-13.72%
Revenue beat(8)1
Avg Revenue beat(8)-29.36%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.34
P/FCF N/A
P/OCF N/A
P/B 0.18
P/tB 2.38
EV/EBITDA N/A
EPS(TTM)-5.77
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-6.23
FCFYN/A
OCF(TTM)-5.15
OCFYN/A
SpS1.55
BVpS2.9
TBVpS0.22
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -834.91%
ROE -2111.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.75%
FCFM N/A
ROA(3y)-253.79%
ROA(5y)-164.97%
ROE(3y)-621.14%
ROE(5y)-405.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y183.27%
GM growth 5Y9.66%
F-Score3
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 60.26%
Cap/Sales 69.14%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.58
Quick Ratio 0.57
Altman-Z -21.69
F-Score3
WACC8.82%
ROIC/WACCN/A
Cap/Depr(3y)213.15%
Cap/Depr(5y)317.62%
Cap/Sales(3y)203.45%
Cap/Sales(5y)994.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.6%
EPS Next Y25.62%
EPS Next 2Y41.4%
EPS Next 3Y26.1%
EPS Next 5YN/A
Revenue 1Y (TTM)13.75%
Revenue growth 3Y245.59%
Revenue growth 5Y44.1%
Sales Q2Q%131.54%
Revenue Next Year312.22%
Revenue Next 2Y289.54%
Revenue Next 3Y175.51%
Revenue Next 5YN/A
EBIT growth 1Y47.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year44.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y38.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y34.72%
OCF growth 3YN/A
OCF growth 5YN/A

META MATERIALS INC / MMAT Fundamental Analysis FAQ

What is the fundamental rating for MMAT stock?

ChartMill assigns a fundamental rating of 2 / 10 to MMAT.


What is the valuation status of META MATERIALS INC (MMAT) stock?

ChartMill assigns a valuation rating of 1 / 10 to META MATERIALS INC (MMAT). This can be considered as Overvalued.


Can you provide the profitability details for META MATERIALS INC?

META MATERIALS INC (MMAT) has a profitability rating of 1 / 10.


How financially healthy is META MATERIALS INC?

The financial health rating of META MATERIALS INC (MMAT) is 1 / 10.


What is the expected EPS growth for META MATERIALS INC (MMAT) stock?

The Earnings per Share (EPS) of META MATERIALS INC (MMAT) is expected to grow by 25.62% in the next year.